Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term tinzaparin vs tinzaparin plus oral anticoagulants for acute pulmonary embolism
2004-002019-97Phase 4Active
- Sponsor
- Farmacusi
- Start
- Dec 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tinzaparin in pulmonary embolism (PE) (2 arms), sponsored by Farmacusi. Primary endpoint: Thromboembolic recurrence. Started Dec 2005; status: active.
02
Drugs
tinzaparin
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on 2004-002019-97.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002019-97.